BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36179631)

  • 1. Improving diagnostic strategies for ovarian cancer in Filipino women using ultrasound imaging and a multivariate index assay.
    Velayo CL; Reforma KN; Sicam RVG; Diwa MH; Sy ADR; Tantengco OAG
    Cancer Epidemiol; 2022 Dec; 81():102253. PubMed ID: 36179631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Performance of a Multivariate Index Assay in Detecting Early-Stage Ovarian Cancer in Filipino Women.
    Velayo CL; Reforma KN; Sicam RVG; Diwa MH; Sy ADR; Tantengco OAG
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performances of Ultrasound-Based Models for Predicting Malignancy in Patients with Adnexal Masses.
    Velayo CL; Reforma KN; Sicam RVG; Diwa MH; Sy ADR; Tantengco OAG
    Healthcare (Basel); 2022 Dec; 11(1):. PubMed ID: 36611467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.
    Shimada K; Matsumoto K; Mimura T; Ishikawa T; Munechika J; Ohgiya Y; Kushima M; Hirose Y; Asami Y; Iitsuka C; Miyamoto S; Onuki M; Tsunoda H; Matsuoka R; Ichizuka K; Sekizawa A
    Int J Clin Oncol; 2018 Jun; 23(3):514-521. PubMed ID: 29236181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
    Tian C; Wen SB; Zhao CY; Yan XN; Du JX
    BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
    Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study.
    Borges AL; Brito M; Ambrósio P; Condeço R; Pinto P; Ambrósio B; Mahomed F; Gama JMR; Bernardo MJ; Gouveia AI; Djokovic D
    Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of IOTA three-step strategy and logistic regression model LR2 for discriminating between benign and malignant adnexal masses.
    Hidalgo JJ; Llueca A; Zolfaroli I; Veiga N; Ortiz E; Alcázar JL
    Med Ultrason; 2021 May; 23(2):168-175. PubMed ID: 33626112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.
    Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the IOTA logistic regression model LR2 for the diagnosis of ovarian cancer.
    Nunes N; Yazbek J; Ambler G; Hoo W; Naftalin J; Jurkovic D
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):355-9. PubMed ID: 22223587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diagnostic efficiency between IOTA LR2 model and doctors
    Zhao B; Fu Y; Wen L; Wang Z; Fu C; Liu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1082-1088. PubMed ID: 36097776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.
    Davenport C; Rai N; Sharma P; Deeks JJ; Berhane S; Mallett S; Saha P; Champaneria R; Bayliss SE; Snell KI; Sundar S
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011964. PubMed ID: 35879201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
    Coleman RL; Herzog TJ; Chan DW; Munroe DG; Pappas TC; Smith A; Zhang Z; Wolf J
    Am J Obstet Gynecol; 2016 Jul; 215(1):82.e1-82.e11. PubMed ID: 26970494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vessel morphology depicted by three-dimensional power Doppler ultrasound as second-stage test in adnexal tumors that are difficult to classify: prospective diagnostic accuracy study.
    Sladkevicius P; Jokubkiene L; Timmerman D; Fischerova D; Van Holsbeke C; Franchi D; Savelli L; Epstein E; Fruscio R; Kaijser J; Czekierdowski A; Guerriero S; Pascual MA; Testa AC; Ameye L; Valentin L
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):324-334. PubMed ID: 32853459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentre external validation of IOTA prediction models and RMI by operators with varied training.
    Sayasneh A; Wynants L; Preisler J; Kaijser J; Johnson S; Stalder C; Husicka R; Abdallah Y; Raslan F; Drought A; Smith AA; Ghaem-Maghami S; Epstein E; Van Calster B; Timmerman D; Bourne T
    Br J Cancer; 2013 Jun; 108(12):2448-54. PubMed ID: 23674083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound examination, MRI, or ROMA for discriminating between inconclusive adnexal masses as determined by IOTA Simple Rules: a prospective study.
    Chacon E; Arraiza M; Manzour N; Benito A; Mínguez JÁ; Vázquez-Vicente D; Castellanos T; Chiva L; Alcazar JL
    Int J Gynecol Cancer; 2023 Jun; 33(6):951-956. PubMed ID: 37055169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
    Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
    Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.